acquired
Stage
About
Apoxis SA was a Swiss company focused on the discovery and development of therapeutics targeting cell death, inflammation, and angiogenesis for the treatment of cancer and autoimmune diseases before merging with TopoTarget A/S.
Explore Apoxis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.